Approval · Notice of Compliance 23069 · 2010
HEPATATE: Notice of Compliance 23069
Issued June 11, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23069
- Date
- June 11, 2010
- Company
- MediamNarcq-En-Baroeul, Nord, France
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer and Product Name Change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HEPATATE | Not yet assigned | — |
Medicinal ingredients
- SODIUM FLUORIDE 1 MG per VIAL
- STANNOUS FLUORIDE 0.125 MG per VIAL